HeartBeam CFO granted options on 53,104 shares

HeartBeam, Inc. reported a routine equity compensation grant to its CFO, Tim Cruickshank.

Rhea-AI Filing Summary

HeartBeam, Inc. reported a routine equity compensation grant to its CFO, Tim Cruickshank. He received stock options covering 53,104 shares of common stock at an exercise price of $1.45 per share. Half of these options vest on March 31, 2026 and the remainder on June 30, 2026 under the 2022 Equity Incentive Plan.

Insider Trade Summary

Grant/Award: 53,104 shares

Grant/Award 1 txn

Insider Cruickshank Tim

Role CFO

Type	Security	Shares	Price	Value
Grant/Award	Common Stock (right to buy)	53,104	$0.00	$0.00

Holdings After Transaction: Common Stock (right to buy) — 53,104 contracts (Direct)

Footnotes (1)

1. F1. Granted options on February 9, 2026 (the "Special Option"), one half of the total number of shares of common stock (the "Shares") subject to the Special Option shall vest on March 31, 2026, the three-month anniversary of the vesting commencement date beginning January 1, 2026, and the remaining Shares of common stock shall vest on June 30, 2026, the six-month anniversary of the vesting commencement date. These options have been issued from the Company's 2022 Equity Incentive Plan.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did HeartBeam (BEAT) report for its CFO?

HeartBeam reported that CFO Tim Cruickshank received a grant of stock options. The award covers 53,104 shares of common stock, providing the right to buy shares at a fixed exercise price under the company’s 2022 Equity Incentive Plan.

How many HeartBeam (BEAT) shares are covered by the new option grant?

The new option grant to the CFO covers 53,104 shares of HeartBeam common stock. These are derivative securities providing a future right to purchase shares, rather than an immediate issuance of common stock today.

What is the exercise price of the HeartBeam (BEAT) CFO’s options?

The granted options allow the CFO to buy HeartBeam common stock at an exercise price of $1.45 per share. This strike price is fixed in the grant and applies through the life of the option, subject to its vesting and expiration terms.

When do the newly granted HeartBeam (BEAT) options vest for the CFO?

Half of the options vest on March 31, 2026, and the remaining half vest on June 30, 2026. The vesting schedule is based on a commencement date of January 1, 2026, creating two time-based vesting tranches for the award.

From which plan were the HeartBeam (BEAT) CFO options issued?

The options granted to the CFO were issued under HeartBeam’s 2022 Equity Incentive Plan. This plan is the company’s framework for awarding equity-based compensation such as stock options to executives and other eligible participants.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/23/2026 - 05:35 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Cruickshank Tim

(Last) (First) (Middle)

2118 WALSH AVE

SUITE 210

(Street)

SANTA CLARA CALIFORNIA 95050

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
HeartBeam, Inc. [ BEAT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CFO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
02/09/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Common Stock (right to buy)	$1.45	02/09/2026		A		53,104		(1)	01/01/2036	Common Stock	53,104	$0	53,104	D

Explanation of Responses:

1. Granted options on February 9, 2026 (the "Special Option"), one half of the total number of shares of common stock (the "Shares") subject to the Special Option shall vest on March 31, 2026, the three-month anniversary of the vesting commencement date beginning January 1, 2026, and the remaining Shares of common stock shall vest on June 30, 2026, the six-month anniversary of the vesting commencement date. These options have been issued from the Company's 2022 Equity Incentive Plan.

	/s/ Tim Cruickshank	03/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)